Tarsus Pharmaceuticals(TARS) Stock Price Today

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

TARS Tarsus Pharmaceuticals

Watchlist

51.010
-0.320-0.62%

Close Mar 26 16:00 ET

51.010
0.0000.00%

Post 16:05 ET

2.10BMarket Cap-16.62P/E (TTM)

Post-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Tarsus Pharmaceuticals Insider Sold Shares Worth $1,163,050, According to a Recent SEC Filing
MT NewswiresMar 21 03:41 ET
Insider Sale: Chief Commercial Officer of $TARS Sells 3,557 Shares
Quiver QuantitativeMar 20 22:00 ET
Sector Update: Health Care Stocks Flat to Lower Premarket Thursday
MT NewswiresMar 13 09:11 ET
Tarsus Pharmaceuticals Specializes in Developing Treatments for Eye-Care Diseases >TARS
Dow JonesMar 12 22:12 ET
Tarsus: Goldman Sachs, BofA Securities Among Managers for Offering >TARS
Dow JonesMar 12 22:09 ET
Tarsus Expects Offering to Close March 14 >TARS
Dow JonesMar 12 22:07 ET

Comments

Peter Koh

Mar 20 20:57

$Tarsus Pharmaceuticals (TARS.US)$ Time to

Jerry Kronenberg

Nov 14, 2024 05:29

Columns Tarsus Pharmaceuticals Gains Some 15% After Hours on Better-Than-Expected Q3 Results

$Tarsus Pharmaceuticals (TARS.US)$ rose some 15% in after-hours trading Wednesday after the biotech reported a narrower-than-Q3 expected loss and better-than-forecast quarterly revenues.
TARS – which makes XDEMVY, a prescription eye drop to treat optical disease Demodex blepharitis – gained 14.5% to $53.25 shortly before 4:30 p.m. ET after unveiling a $0.61 Q3 loss, beating the $0.92 that analysts had reportedly f...

MMu

Oct 30, 2024 04:16

$Tarsus Pharmaceuticals (TARS.US)$ wonder which 2 pharmas are bidding for Tarsus!!

Stock_Drift

Oct 28, 2024 17:33

Pre Market Ticks. 5:32am 10/28

$Jet.AI (JTAI.US)$ $ProShares UltraShort Bloomberg Crude Oil ETF (SCO.US)$ $Phunware (PHUN.US)$ $ImmunityBio (IBRX.US)$ $Longeveron (LGVN.US)$ $BIOSIG TECHNOLOGIES INC (BSGM.US)$ $Tarsus Pharmaceuticals (TARS.US)$ $XTL Biopharmaceuticals (XTLB.US)$ $LENZ Therapeutics (LENZ.US)$ $TC BioPharm (TCBP.US)$ $Top Wealth Group Holding (TWG.US)$ $Healthcare Triangle (HCTI.US)$ $Pixie Dust Technologies(Delisted) (PXDT.US)$
📊⚡️📊

Jaguar8

Aug 9, 2024 04:17

NEWS

$Tarsus Pharmaceuticals (TARS.US)$
Tarsus Reports Second Quarter and Year-to-Date 2024 Financial Results and Recent Business Achievements
Tarsus Pharmaceuticals (NASDAQ: TARS) reported strong Q2 2024 financial results, with XDEMVY® net product sales reaching $40.8 million, a 65% increase from Q1.
Year-to-date sales totaled $65.5 million.
The company delivered over 37,000 bottles to patients in Q2 and achieved an impressive gross-to-net discount of 44%.
Tarsus expanded payer coverage, incl...

TARS Tarsus Pharmaceuticals

Trade Overview

Capital Trend

News

Comments

Market Insights